WisdomInterface

Sartorius Stedim BioOutsource Increases Value for its Clients with Biopharmaceutical Platform Solution with UNIFI

Adds Structural Characterization of Novel Monoclonal Antibodies and Biosimilars by LC-MS to Testing Capabilities

Sartorius Stedim BioOutsource, a part of the Sartorius Stedim Biotech (SSB) Group since 2015, provides a comprehensive range of contract testing services for biologics, vaccines, and biosimilars throughout development and manufacture. Its goal is to provide customers with the most timely, accurate, and comprehensive data to support regulatory submissions.

Download this case study to learn how Sartorius Stedim BioOutsource integrated LC-MS technology with UNIFI to link mAb structural analysis to biological function and accelerate biosimilar development.

SUBSCRIBE

    Subscribe for more insights



    By completing and submitting this form, you understand and agree to WisdomInterface processing your acquired contact information as described in our privacy policy.

    No spam, we promise. You can update your email preference or unsubscribe at any time and we'll never share your details without your permission.

      Subscribe for more insights




      By completing and submitting this form, you understand and agree to WisdomInterface processing your acquired contact information as described in our privacy policy.

      No spam, we promise. You can update your email preference or unsubscribe at any time and we'll never share your details without your permission.

      This also includes the use of email tracking technologies, such as tracking pixels, to measure email opens and engagement, as described in our privacy policy.